Skip to main content
Premium Trial:

Request an Annual Quote

Mass General, CHOP, Northwestern Med Get FDA EUAs for SARS-CoV-2 Tests

NEW YORK – Massachusetts General Hospital, the Infectious Disease Diagnostics Laboratory at Children's Hospital of Philadelphia (CHOP), and the Diagnostic Molecular Laboratory at Northwestern Medicine, have received Emergency Use Authorization from the US Food and Drug Administration for tests to detect SARS-CoV-2.

All three organization's real-time RT-PCR tests were cleared by the FDA last week for detecting  SARS-CoV-2 using nasopharyngeal swabs, nasal swabs, and bronchoalveolar lavage specimens.

The FDA granted EUAs for the three tests under guidance released by the agency on March 31 for molecular-based, laboratory-developed tests for detecting the coronavirus. 

Massachusetts General's MGH SARS-CoV-2 assay can be used with Roche's Cobas Z 480 real-time PCR analyzer, Thermo Fisher Scientific's Applied Biosystems QuantStudio 7 Flex Real-Time PCR system, and Thermo Fisher's ViiA 7 Real-Time PCR system. RNA extraction for the test is done with Qiagen's QIAamp Viral RNA Mini Kit. 

The SARS-CoV-2 RT-PCR Test from CHOP also works with nasopharyngeal and tracheal aspirates and is used with the Roche MagNaPure LC Total Nucleic Acid extraction platform and Thermo Fisher Scientific's Applied Biosystems Quant DX PCR platform. Testing is limited to the hospital's CLIA-certified Infectious Disease Diagnostics Laboratory. 

The Northwestern Medicine SARS-CoV-2 Assay uses reagents, primers, and probes that were developed by the US Centers for Disease Control and Prevention, which received EUA in February. It also works with oropharyngeal swabs and is meant for use with Thermo Fisher Scientific's Applied Biosystems Quant Studio 6 Flex instrument. The assay will be performed in the CLIA-certified Northwestern Diagnostic Molecular Laboratory.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.